相关实验视频
Updated: Jun 23, 2025
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
9.9K
瘤微环境:致病的一般原理和扩散型大B细胞淋巴瘤的影响
Stanislavs Sinkarevs1, Boriss Strumfs1, Svetlana Volkova1
1Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Cells
|June 26, 2024
概括
扩散性大B细胞淋巴瘤 (DLBCL) 治疗失败可能源于瘤微环境 (TME). 了解TME组件为DLBCL患者改善治疗结果提供了新的治疗目标.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的非霍奇金淋巴瘤,复发率高或耐药性疾病.
- 在DLBCL中治疗失败通常与瘤微环境 (TME) 内的复杂相互作用有关.
研究的目的:
- 审查DLBCL.L.中对TME组件的最新理解.
- 讨论TME在瘤进展和免疫抑制中的作用.
- 在TME中识别诊断标记和新的治疗点.
主要方法:
- 对DLBCL和瘤微环境的当前研究的文献综述.
- 分析各种TME细胞的作用,包括TAMs,MDSCs,TANs,CAFs,CD8+细胞和T调控细胞.
- 确定关键的诊断标志物和潜在的治疗策略.
主要成果:
- TME包括与DLBCL细胞相互作用的多种细胞类型 (TAM,MDSC,TAN,CAF,T细胞).
- 这些相互作用有助于免疫抑制和患者预后不佳.
- 特定的TME组件及其标记物为向治疗提供了机会.
结论:
- 了解DLBCL TME对于开发有效治疗方法至关重要.
- 针对TME组件提供了一个有希望的途径来克服治疗耐药性.
- 对TME元素的进一步研究可以显著提高DLBCL患者的生存率.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510